Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway

Sepsis is a leading cause of death in patients with severe infection worldwide. Remifentanil is an ultra-short-acting, potent opioid analgesic. In the study, we aimed to investigate the role and underlying mechanism of remifentanil in lipopolysaccharide- (LPS-) induced inflammation in human aortic e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mediators Inflamm
Asıl Yazarlar: Zhang, Jian-ning, Ma, Yang, Wei, Xi-yan, Liu, Ke-yin, Wang, Hao, Han, Hui, Cui, Yi, Zhang, Ming-xiang, Qin, Wei-dong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012251/
https://ncbi.nlm.nih.gov/pubmed/32082073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3013716
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller